Roivant Sciences (ROIV) EBT Margin (2020 - 2026)
Roivant Sciences (ROIV) recorded EBT Margin of -20427.46% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 8019.07 percentage points from -12408.39% a year earlier and down 38447.18 percentage points from the prior quarter.
Roivant Sciences (ROIV) EBT Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' EBT Margin came in at -3848.65% as of Jun 30, 2026, up 159.50 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -3203.12%, down 857.10 percentage points from FY2025.
- Annual EBT Margin has a five-year change of +573.08 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, EBT Margin came in at -2346.02% in FY2025 (-16309.45 pp), 13963.43% in FY2024 (+16770.25 pp), -2806.82% in FY2023 (-1135.97 pp) and -1670.85% in FY2022 (+2105.35 pp).
- The fiscal Q1 2027 figure is the lowest quarterly EBT Margin in data going back to fiscal Q1 2021.
- On a year-over-year basis, EBT Margin rose in two of the last eight quarters, with an average year-over-year change of -6524.17 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 35356.87 percentage points in fiscal Q3 2024, against a drop of 35716.71 percentage points in fiscal Q3 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 18019.72% (Q4 2026), -14525.71% (Q3 2026) and -10123.74% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | -20,427.46% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20,427.46% |
| Mar 31, 2026 | 18,019.72% |
| Dec 31, 2025 | -14,525.71% |
| Sep 30, 2025 | -10,123.74% |
| Jun 30, 2025 | -12,408.39% |
| Mar 31, 2025 | -2,682.35% |
| Dec 31, 2024 | -2,600.50% |
| Sep 30, 2024 | -5,014.15% |
| Jun 30, 2024 | -245.81% |
| Mar 31, 2024 | -1,116.75% |
| Dec 31, 2023 | 33,116.21% |
| Sep 30, 2023 | -6,617.49% |
| Jun 30, 2023 | -1,508.01% |
| Dec 31, 2022 | -2,240.66% |
| Sep 30, 2022 | -2,503.44% |
| Jun 30, 2022 | -8,098.75% |
| Mar 31, 2022 | -3,160.32% |
| Dec 31, 2021 | -1,257.33% |
| Sep 30, 2021 | -1,610.35% |
| Jun 30, 2021 | -1,305.56% |
Roivant Sciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();